News for Pfizer Inc. (PFE.BE)

(Bloomberg) -- Canada’s public health agency licensed Johnson & Johnson’s coronavirus vaccine, making it the fourth shot authorized in a country struggling to keep up with its Group of Seven peers on inoculations. The approval, first reported by Canadian Broadcasting Corp.

The government’s target is to vaccinate every Canadian that wants a shot by the end of September.Pfizer vaccine was the first to be approved in Canada on Dec. 9 followed by Moderna Inc.’s vaccine which was licensed two weeks later on Dec. 23 and AstraZeneca Plc’s vaccine was authorized on Feb 26

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast...

Canadian regulators have given the green light to Johnson & Johnson’s (NYSE:JNJ) COVID-19 vaccine.

Japanese Prime Minister Yoshihide Suga announced that his government is extending a state of emergency in the Tokyo region for another two weeks because its medical systems are still strained by COVID-19 patients.

As most economies in the rich world cratered last year, Ireland’s grew. Behind that success: thriving drug and tech companies, lured to the country over the years by low tax rates, that hit a sweet spot in the coronavirus pandemic.

With vaccinations lagging, Indonesia’s government has authorized private companies to acquire Covid-19 vaccines, but some public-health experts say the strategy will steer shots toward the middle-class and wealthy.

A botched deal last year between Canada and Chinese vaccine manufacturer CanSino Biologics Inc. laid bare this country’s vulnerabilities amid efforts to devise a proper immunization plan.

The supply disruption concerns have arisen after the Biden administration announced plans to use the Defense Production Act to boost supplies needed to make Pfizer Inc.’s vaccines

By Michael Wursthorn and Sebastian Pellejero The VanEck Vectors Social Sentiment ETF started trading Thursday in a bid to play off the retail-investing boom and the buzz investors are creating... | March 4, 2021

B.C.’s top doctor is expressing regret over how the province communicated to those expecting to get their second COVID-19 vaccine dose before those appointments were cancelled.

The exchange-traded fund doesn’t include GameStop or AMC, but it does have Tesla, DraftKings and other stocks frequently talked up on Reddit and Twitter.

More provinces may be jumping on board with B.C.’s plans to immunize more residents against COVID-19 by delaying the interval between doses by up to four months.

PUNE, India, March 04, 2021 (GLOBE NEWSWIRE) -- The Global Multiple Sclerosis Drugs Market Share, Trends, Analysis and Forecasts, 2020-2030 provides ...

The Swiss drug company will make mRNA and other parts of CureVac’s two-dose vaccine, which is in late-stage testing with results expected as soon as next month.

CARMIEL, Israel, March 4, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the

Today's Daily Dose brings you news about KemPharm scoring regulatory nod for its ADHD drug, expanded FDA approval for Pfizer's Lorbrena, United Therapeutics scrapping the development of Trevyent, Vir Biotechnology closing the enrollment in VIR-7831 arm of ACTIV-3 trial, and Takeda securing global rights to Ovid's investigational medicine Soticlestat.

Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious and

By Sabrina Siddiqui and Tarini Parti Merck & Co. will help produce Johnson & Johnson's single-dose Covid-19 vaccine, President Biden plans to announce Tuesday, as the administration... | March 2, 2021